(Q36486840)

English

Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes (English)

1 reference

Europe PubMed Central

14 August 2017

0 references

0 references

bacterial pneumonia

1 reference

based on heuristic

inferred from title

author name string

George H Talbot

1

1 reference

Europe PubMed Central

14 August 2017

John H Powers

2

1 reference

Europe PubMed Central

14 August 2017

Thomas R Fleming

3

1 reference

Europe PubMed Central

14 August 2017

Judith A Siuciak

4

1 reference

Europe PubMed Central

14 August 2017

John Bradley

5

1 reference

Europe PubMed Central

14 August 2017

Helen Boucher

6

1 reference

Europe PubMed Central

14 August 2017

CABP-ABSSSI Project Team

7

1 reference

Europe PubMed Central

14 August 2017

language of work or name

0 references

publication date

28 June 2012

1 reference

Europe PubMed Central

14 August 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

14 August 2017

55

1 reference

Europe PubMed Central

14 August 2017

8

1 reference

Europe PubMed Central

14 August 2017

1114-1121

1 reference

Europe PubMed Central

14 August 2017

Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

30 September 2017

Fidaxomicin versus vancomycin for Clostridium difficile infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

30 September 2017

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

30 September 2017

THE TREATMENT OF PNEUMOCOCCIC PNEUMONIA WITH SULFAPYRIDINE

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

30 September 2017

IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

30 September 2017

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

30 September 2017

Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

28 June 2018

Sulphanilamide in the Treatment of Erysipelas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

21 September 2018

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

21 September 2018

Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

21 September 2018

Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3529608

21 September 2018

Pneumoccocal pneumonia treated with penicillin and aspirin

1 reference

https://pubmed.ncbi.nlm.nih.gov/22744885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prontosil in Erysipelas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22744885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22744885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/CID/CIS566

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36486840&oldid=1523693154"